Autism Clinical Trial
Official title:
An Investigation Into the Outcome of NAET Treatment on Children With Allergy-Related Autism Spectrum Disorders in a Multi-Clinical Setting.
1. Purpose of this study is to determine whether NAET procedures are effective in the
treatment of children with allergy-related autism spectrum disorders in restoring their
verbal and nonverbal communication.
2. Hypothesis: Children in the experimental group will show a significant improvement over
the control group in verbal and nonverbal communication as most food allergen groups,
environmental allergen groups, childhood immunizations, and some other relevant
allergenic substances are desensitized in a systematic way using NAET® procedures
within the specified period of study.
Status | Completed |
Enrollment | 48 |
Est. completion date | May 2007 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Years to 10 Years |
Eligibility |
Inclusion Criteria: all subjects (control and treatment group) should demonstrate typical autistic symptoms before beginning NAET® treatments: made no eye contact, unable to communicate verbally or nonverbally. All subjects should bring in a proof of established diagnosis of autism spectrum disorder by a conventional physician. Exclusion Criteria: Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Any patient who has any of the following conditions will also be disqualified. 1. Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc. 2. Any type of cancer 3. Aids 4. Any physically debilitating disorders and diagnosed mental retardation, Down’s syndrome, etc. 5. Children with the history of severe allergies or anaphylactic reactions will be exclued. |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | NAET Pain Clinic | Buena Park | California |
Lead Sponsor | Collaborator |
---|---|
Nambudripad's Allergy Research Foundation | Anonymous |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Improvement in verbal and norverbal communication | Twenty-four months from the starting date (approximately may 2008) | ||
Secondary | Reduction of commonly seen autistic traits | Twenty-four months from starting dat (May 2008) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|